Research offers a cost-effectiveness analysis of anticoagulant drugs for cancer-associated thrombosis

A network of molecules and atoms of glass and crystals constitute a single system. 3D illustration

Newly published research out of the University of Cincinnati and the University of California-Davis shows that direct oral anticoagulant (DOAC) drugs are more effective and are more cost-effective than low molecular weight heparin for treating cancer-associated thrombosis.

Researchers discover novel candidate drug targets for advanced non-alcoholic fatty liver disease

Previous article

CES 2023: Samsung previews a new TV mode for the visually impaired

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News